Autoimmunity Reviews

Article	Citations
Editorial Board	189
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	150
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	139
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies	126
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	116
The Trm-Treg Axis as a tissue-encoded immune checkpoint in chronic inflammation and autoimmunity	111
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	105
Endometriosis and autoimmunity	100
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	99
Editorial Board	98
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives	96
Susac syndrome: A scoping review	94
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	93
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	85
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)	83
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance	80
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	79
Comment on “Meta-analysis of meteorological conditions and rheumatoid arthritis”	78
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	74
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies	71
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	66
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	63
Metabolic traits of T cells and the implications in autoimmune diseases	62
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	61
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	61

Editorial Board	61
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	56
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 24	55
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis	54
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	54
Autoimmune pre-disease	52
STING-inflammasome axis in autoimmune diseases and inflammation-related disease	52
Autoimmunity, diet and autophagy	51
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	51
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	51
Psychiatric manifestations of autoimmune encephalitis	51
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	50
Can anticoagulation be withdrawn in APS patients after aPL negativization?	47
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	47
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	46
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease	46
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	46
Seronegative autoimmune diseases: A challenging diagnosis	45
Editorial Board	44
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives	44
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	43
Editorial Board	42
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	40
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	40
SpA plus IBD or IBD plus SpA: Does commutative property apply?	40
Adipose failure through adipocyte overload and autoimmunity	39
Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review	39
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	38
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	38
Chinese recommendations for the diagnosis and management of non-radiographic axial spondyloarthritis	38
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	38
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	38
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	38
VEXAS syndrome in adults: A narrative review of genomic pathogenesis, multisystem phenotypes, diagnostic algorithms, and emerging therapeutic strategies	37
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	37
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	36
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	35
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	35
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	34
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	34
Chronic inflammation in Long COVID relationship to autoimmune diseases	34
Regulatory mechanisms and targeted therapeutic strategies of glycolytic metabolism in rheumatoid arthritis	34
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	34
Mechanisms of environmental risk factors for autoimmune diseases	34
Development of an algorithm for IgG4-related disease management	34
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	34
Editorial Board	34
Tumor necrosis factor-α inhibitor-related autoimmune disorders	34
LAG-3 in (auto)immunity and cancer - Emphasising its role in antigen presenting cells	34
The role of mitochondrial dysfunction in kidney injury and disease	33

Fibromyalgia: Are we using the biopsychosocial model?	33
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	33
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	33
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	33
Editorial Board	32
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	32
Alarmins in autoimmune diseases	32
Editorial Board	32
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy	32
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	31
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	31
Reply letter to letter to the editor	31
Are IF-ANA the guiding light for SLE classification in the real-world setting?	31
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	31
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	30
Editorial Board	30
Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review	30
Coffee consumption and risk of multiple sclerosis: A systematic review and meta-analysis	30
Twenty shades of the mosaic of autoimmunity	30
Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis	29
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	29
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	28
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	28
Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis	28
IL-33 in Spondyloarthritis, the missing key	27
The impact of pregnancy on future health in Rheumatoid Arthritis: A systematic review of the literature	27
Editorial Board	27
Cutting edge confusion about cut-off settings in autoimmune diagnostics	27
Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review	27
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	27
In Memoriam: Pierre Youinou	27
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	26
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	26
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	26
Angiogenic imbalance and endothelial dysfunction in the placenta in antiphospholipid syndrome	26
Neuroimaging in thyroid eye disease: A systematic review	25
Anti-CD52 therapy of rheumatic diseases: Revisited in the era of immune reset	25
Is it time for treat-to-target in antiphospholipid syndrome?	25
Imaging the hidden player: Choroid plexus enlargement in multiple sclerosis	24
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	24
Editorial Board	24
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	24
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	24
JAK inhibitors and systemic sclerosis: A systematic review of the literature	24
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	23
Serum calprotectin is a marker of disease activity in Giant cell arteritis	23
Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives	23
Diagnostic approach in giant cell arteritis	23
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	23
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	23
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	23
Extending the discussion: Cannabis based therapies in inflammatory bowel disease a letter to the editor	23
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	23
Ferritinophagy in inflammatory and autoimmune diseases: Mechanistic insights and therapeutic potentials	23
Persistent aortic inflammation in patients with giant cell arteritis	22
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	22
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	22
From inflammation to renal fibrosis: A one-way road in autoimmunity?	22
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	22
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	22
Editorial Board	21
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	21
Rapid radiographic progression in rheumatoid arthritis: Definition, prediction and treatment	21
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	21
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	20
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	20
Intermittent fasting: A promising dietary intervention for autoimmune diseases	20
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	20
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	20
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	20
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	20
Editorial Board	20
Don't mix apples and oranges. Reply to Azoulay et al.	20
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	20
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	20
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	19
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	19
Regulated cell death in systemic lupus erythematosus: Key pathways and targeted therapies	19
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	19

Emerging roles of mechanically activated ion channels in autoimmune disease	19
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overview	19
Heavy and trace metals toxicity implications in the breakdown of cellular homeostasis: A risk factor for rheumatoid arthritis pathogenesis	18
Involvement of aquaporin 5 in Sjögren’s syndrome	18
Systemic lupus erythematosus in critical care: A systematic review of ICU outcomes and management	18
Prevention of rheumatoid arthritis using a familial predictive medicine approach	18
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	18
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	18
Editorial Board	17
Clinical features, pathogenesis, and treatment of inflammatory bowel disease-associated spondyloarthritis	17
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	17
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	17
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	17
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	17
Anti-glomerular basement membrane vasculitis	17
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	17
Insights into new-onset autoimmune diseases after COVID-19 vaccination	17
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	17
Editorial Board	16
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	16
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	16
From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies	16
Outcomes of ICU patients treated with intravenous immunoglobulin for sepsis or autoimmune diseases	16
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	16
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	16
Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions	16
Does a window of opportunity for rheumatoid arthritis-associated interstitial lung disease exist?	16
Relapses in giant cell arteritis: Updated review for clinical practice	16
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	16
Exploring vaccine safety and adverse events in major autoimmune diseases	16
Ethics in publishing: From plagiarism to artificial intelligence	16
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies	16
Macrophage metabolic reprogramming: A trigger for cardiac damage in autoimmune diseases	15
Letter to the editor: Keratitis fugax hereditaria is an eye-specific cryopyrin-associated periodic syndrome	15
The entrenchment of NLRP3 inflammasomes in autoimmune disease-related inflammation	15
Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry	15
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	15
Vagus nerve stimulation in autoimmune diseases: Mechanisms, therapeutic potential, and clinical applications	15
Editorial Board	15
Cardiovascular risk in psoriatic arthritis: How can we manage it?	15
Intravenous immunoglobulin as a therapy for autoimmune conditions	15
Single centre experience of 120 patients with non-infectious aortitis: Clinical features, treatment and complications	15
The role of γδ T cells and CAR-γδ T cell therapy in autoimmune diseases	15
Isolated antineutrophil cytoplasmic antibody–associated interstitial lung disease: A systematic review of an emerging condition	15
Corrigendum to “Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience” [Autoimmunity Reviews, Volume 20, Iss	15
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?	15
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation	15
Editorial Board	15
The roles of S100A8/A9 and S100A12 in autoimmune diseases: Mechanisms, biomarkers, and therapeutic potential	15
Obstetric antiphospholipid syndrome: Advances in pathogenesis	15
Exploring the metabolic mysteries: Mechanistic insights into lactylation-mediated regulation of autoimmune diseases	15
Editorial Board	14
Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype	14
Macrophage polarization regulates the pathogenesis and progression of autoimmune diseases	14
ChatGPT and autoimmunity – A new weapon in the battlefield of knowledge	14
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis	14
Efficacy, safety, and tolerability of antifibrotic agents in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	14
Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides	14
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets	14
Cognitive impairment in systemic autoimmune and inflammatory diseases: A narrative review focused on ANCA-associated vasculitis, sarcoidosis, Sjögren's syndrome, systemic sclerosis, and Behçet's disea	14
Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus	14
Short-term and low-dose IL-2 therapy increases the reduced Treg cells in patients with microscopic polyangiitis	13
B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis	13
Residual pain in rheumatoid arthritis: Is it a real problem?	13
Current state of epigenetics in giant cell arteritis: Focus on microRNA dysregulation	13
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task force	13
The role of interleukin inhibitors in the treatment of hidradenitis suppurativa; a systematic review of clinical trials	13
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019	13
Effects of biologics and small-molecule inhibitors on lipid profiles in patients with psoriasis or psoriatic arthritis: An analysis of current evidence	13
Environmental toxins and toxic metals in autoimmune diseases: Sex differences, hormonal influences, and immune dysregulation	13
Renal involvement in systemic sclerosis	13
Social determinants of health and disparities across the Patient pathway in Systemic Lupus Erythematosus: a narrative review	13
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review	13
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort	13
Building a monitoring matrix for the management of multiple sclerosis	13
Association between breastfeeding and the risk of autoimmune diseases: A systematic review and meta-analysis	13
SLE patients with childhood-onset: A nation-wide population-based study	13
Exposome: Epigenetics and autoimmune diseases	13
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and exper	13
Aquaporins: Unexpected actors in autoimmune diseases	12
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of immunological host defense and autoimmune imprinting	12
Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus	12
Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019	12
Global analysis of antiphospholipid syndrome and stroke research: identifying emerging trends, international collaborations, and knowledge gaps	12
Effects of nutritional supplements and dietary interventions on rheumatoid arthritis: An umbrella review of meta-analyses of randomized controlled trials	12
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases	12
Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease	12
Unraveling the global burden of inflammatory bowel disease (1990–2019): A Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts	12
Immunometabolic shifts in autoimmune disease: Mechanisms and pathophysiological implications	12
Targeting autoimmunity: Phosphodiesterase inhibitors as immunomodulators—a review of current insights and future direction	12
Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis	12
Is it safe to withdraw low-dose glucocorticoids in SLE patients in remission?	12
Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues	12
Editorial Board	12
Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study	11